Global Intravascular Ultrasound
Market Report
2025
Delivery Includes:- Market Timeline 2021 till 2033, Market Size, Revenue/Volume Share, Forecast and CAGR, Competitor Analysis, Regional Analysis, Country Analysis, Segment Analysis, Market Trends, Drivers, Opportunities, Restraints, ESG Analysis, Porters Analysis, PESTEL Analysis, Market Attractiveness, Patent Analysis, Technological Trend, SWOT Analysis, COVID-19 Analysis, Consumer Behavior Analysis, etc.
The base year for the calculation is 2024. The historical will be 2021 to 2024. The year 2025 will be estimated one while the forecasted data will be from year 2025 to 2033. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Intravascular Ultrasound Market Report 2025.
According to Cognitive Market Research, the global Intravascular UltraSound market size will be USD XX million in 2025. It will expand at a compound annual growth rate (CAGR) of XX% from 2025 to 2033.
2021 | 2025 | 2033 | CAGR | |
---|---|---|---|---|
Global Intravascular Ultrasound Market Sales Revenue | $ 563.3 Million | $ 732 Million | $ 1236.1 Million | 6.768% |
North America Intravascular Ultrasound Market Sales Revenue | $ 224.76 Million | $ 285.48 Million | $ 463.523 Million | 6.246% |
United States Intravascular Ultrasound Market Sales Revenue | $ 151.713 Million | $ 189.844 Million | $ 298.509 Million | 5.821% |
Canada Intravascular Ultrasound Market Sales Revenue | $ 53.7177 Million | $ 69.6571 Million | $ 117.271 Million | 6.728% |
Mexico Intravascular Ultrasound Market Sales Revenue | $ 19.3294 Million | $ 25.9787 Million | $ 47.7429 Million | 7.904% |
Europe Intravascular Ultrasound Market Sales Revenue | $ 160.543 Million | $ 205.692 Million | $ 338.681 Million | 6.432% |
United Kingdom Intravascular Ultrasound Market Sales Revenue | $ 31.3059 Million | $ 41.7555 Million | $ 74.1711 Million | 7.446% |
Germany Intravascular Ultrasound Market Sales Revenue | $ 30.9848 Million | $ 40.5213 Million | $ 69.4296 Million | 6.963% |
France Intravascular Ultrasound Market Sales Revenue | $ 19.4257 Million | $ 25.0944 Million | $ 41.9964 Million | 6.648% |
Italy Intravascular Ultrasound Market Sales Revenue | $ 11.3986 Million | $ 13.9871 Million | $ 20.3208 Million | 4.78% |
Russia Intravascular Ultrasound Market Sales Revenue | $ 9.472 Million | $ 11.7244 Million | $ 18.2888 Million | 5.715% |
Spain Intravascular Ultrasound Market Sales Revenue | $ 14.9305 Million | $ 17.8952 Million | $ 26.0784 Million | 4.82% |
Sweden Intravascular Ultrasound Market Sales Revenue | $ 7.385 Million | $ 8.8448 Million | $ 13.5472 Million | 5.474% |
Denmark Intravascular Ultrasound Market Sales Revenue | $ 8.6693 Million | $ 10.696 Million | $ 16.2567 Million | 5.372% |
Switzerland Intravascular Ultrasound Market Sales Revenue | $ 5.9401 Million | $ 7.1992 Million | $ 10.8378 Million | 5.246% |
Luxembourg Intravascular Ultrasound Market Sales Revenue | $ 2.7292 Million | $ 3.2911 Million | $ 4.7415 Million | 4.67% |
Rest of Europe Intravascular Ultrasound Market Sales Revenue | $ 18.3019 Million | $ 24.683 Million | $ 43.0125 Million | 7.189% |
Asia Pacific Intravascular Ultrasound Market Sales Revenue | $ 108.719 Million | $ 148.596 Million | $ 275.642 Million | 8.029% |
China Intravascular Ultrasound Market Sales Revenue | $ 40.7695 Million | $ 57.6552 Million | $ 112.737 Million | 8.744% |
Japan Intravascular Ultrasound Market Sales Revenue | $ 22.8309 Million | $ 29.2734 Million | $ 47.9616 Million | 6.366% |
India Intravascular Ultrasound Market Sales Revenue | $ 11.8503 Million | $ 17.2371 Million | $ 36.3847 Million | 9.788% |
South Korea Intravascular Ultrasound Market Sales Revenue | $ 13.5898 Million | $ 18.4259 Million | $ 33.6283 Million | 7.81% |
Australia Intravascular Ultrasound Market Sales Revenue | $ 5.7621 Million | $ 7.5784 Million | $ 12.6795 Million | 6.645% |
Singapore Intravascular Ultrasound Market Sales Revenue | $ 3.1528 Million | $ 4.0121 Million | $ 6.0641 Million | 5.299% |
South East Asia Intravascular Ultrasound Market Sales Revenue | $ 5.1098 Million | $ 6.8354 Million | $ 12.1282 Million | 7.431% |
Taiwan Intravascular Ultrasound Market Sales Revenue | $ 3.479 Million | $ 4.4579 Million | $ 7.718 Million | 7.102% |
Rest of APAC Intravascular Ultrasound Market Sales Revenue | $ 2.1744 Million | $ 3.1205 Million | $ 6.3398 Million | 9.265% |
South America Intravascular Ultrasound Market Sales Revenue | $ 33.2352 Million | $ 43.92 Million | $ 75.3997 Million | 6.989% |
Brazil Intravascular Ultrasound Market Sales Revenue | $ 15.255 Million | $ 20.0714 Million | $ 33.9299 Million | 6.783% |
Argentina Intravascular Ultrasound Market Sales Revenue | $ 5.7165 Million | $ 7.4225 Million | $ 12.2902 Million | 6.506% |
Colombia Intravascular Ultrasound Market Sales Revenue | $ 2.9247 Million | $ 4.0846 Million | $ 7.8416 Million | 8.494% |
Peru Intravascular Ultrasound Market Sales Revenue | $ 1.8944 Million | $ 2.6352 Million | $ 4.901 Million | 8.065% |
Chile Intravascular Ultrasound Market Sales Revenue | $ 3.7223 Million | $ 4.963 Million | $ 8.7464 Million | 7.34% |
Rest of South America Intravascular Ultrasound Market Sales Revenue | $ 3.7223 Million | $ 4.7434 Million | $ 7.6908 Million | 6.227% |
Middle East Intravascular Ultrasound Market Sales Revenue | $ 20.8424 Million | $ 27.816 Million | $ 49.4424 Million | 7.455% |
Saudi Arabia Intravascular Ultrasound Market Sales Revenue | $ 8.0243 Million | $ 11.0151 Million | $ 20.5681 Million | 8.119% |
Turkey Intravascular Ultrasound Market Sales Revenue | $ 4.3561 Million | $ 5.7579 Million | $ 10.0368 Million | 7.193% |
UAE Intravascular Ultrasound Market Sales Revenue | $ 3.3973 Million | $ 4.5618 Million | $ 8.158 Million | 7.536% |
Egypt Intravascular Ultrasound Market Sales Revenue | $ 2.2301 Million | $ 2.9207 Million | $ 5.0431 Million | 7.066% |
Qatar Intravascular Ultrasound Market Sales Revenue | $ 1.2089 Million | $ 1.5021 Million | $ 2.3238 Million | 5.606% |
Rest of Middle East Intravascular Ultrasound Market Sales Revenue | $ 1.6257 Million | $ 2.0584 Million | $ 3.3126 Million | 6.128% |
Africa Intravascular Ultrasound Market Sales Revenue | $ 15.2093 Million | $ 20.496 Million | $ 33.3736 Million | 6.284% |
Nigeria Intravascular Ultrasound Market Sales Revenue | $ 4.1369 Million | $ 5.6774 Million | $ 9.5449 Million | 6.709% |
South Africa Intravascular Ultrasound Market Sales Revenue | $ 5.81 Million | $ 7.6245 Million | $ 11.7142 Million | 5.515% |
Rest of Africa Intravascular Ultrasound Market Sales Revenue | $ 5.2624 Million | $ 7.1941 Million | $ 12.1146 Million | 6.731% |
Base Year | 2024 |
Historical Data Time Period | 2021-2024 |
Forecast Period | 2025-2033 |
Market Split by Type |
|
Market Split by End-user |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Report scope is customizable as we have a huge database of Intravascular Ultrasound industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Intravascular Ultrasound Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Intravascular Ultrasound (IVUS) Market Overview
According to Cognitive Market Research, the global Intravascular Ultrasound Market is estimated to grow at a CAGR of XX% during the forecast period. Intravascular ultrasound (IVUS) is a catheter-based imaging technique that provides real-time, cross-sectional images of blood vessels from the inside out. Primarily used in interventional cardiology, IVUS aids in assessing plaque burden, guiding stent placement, and evaluating vessel morphology. The global IVUS market is experiencing significant growth, driven by the rising prevalence of cardiovascular diseases (CVDs), technological advancements, and increasing adoption of minimally invasive procedures.
The burden of CVDs remains substantial worldwide. According to the World Health Organization, CVDs are the leading cause of death globally, accounting for an estimated 17.9 million deaths each year. This underscores the need for advanced diagnostic tools like IVUS to improve patient outcomes.
Technological innovations are enhancing IVUS capabilities. For instance, Boston Scientific's AVVIGO+ Multi-Modality Guidance System integrates high-definition IVUS with automated lesion assessment, employing machine learning to detect lumen and vessel borders automatically, providing precise vessel measurements. Such advancements are streamlining procedures and improving diagnostic accuracy.
(Source: https://www.jscai.org/article/S2772-9303%2824%2902195-1/fulltext
AVVIGO™+ Multi-Modality Guidance System - Boston Scientific)
Geographically, Japan leads in IVUS adoption, with usage rates exceeding 80% in percutaneous coronary interventions (PCIs), attributed to favourable reimbursement policies and early adoption of imaging-guided interventions. In contrast, the United States has lower adoption rates, though initiatives by the American College of Cardiology (ACC) are promoting increased use of intravascular imaging to improve PCI outcomes.
(Source: Cardiovascular Business)
Market Dynamics – Key Drivers
The increasing burden of cardiovascular diseases (CVDs) globally is driving the growing demand for intravascular ultrasound. Historically, coronary artery disease and related conditions were diagnosed primarily using X-ray angiography, which, while useful, lacked the detailed imaging necessary to assess vessel wall characteristics and plaque burden effectively.
As CVDs have become the leading cause of death worldwide—responsible for an estimated 17.9 million deaths annually according to the World Health Organization—the need for more advanced, precise diagnostic tools has surged. IVUS enables physicians to visualize arterial walls from within, allowing for better stent placement, plaque detection, and risk stratification during percutaneous coronary interventions (PCIs).
For instance, the WHO’s global health data confirms that ischemic heart disease remains the top cause of mortality, underscoring the demand for improved interventional tools that help reduce complications and optimize outcomes in patients with coronary artery disease.
(Source: World Health Organization – Cardiovascular Diseases)
Consequently, hospitals and cardiac centers are increasingly adopting IVUS to enhance procedural precision and long-term treatment success in CVD management.
The evolution of interventional cardiology toward image-guided procedures is significantly boosting the adoption of intravascular ultrasound. Previously, stent placement was guided solely by angiographic imaging, which offers limited information about the arterial wall and lesion morphology, leading to risks of under-expansion or misplacement.
Intravascular ultrasound addresses these limitations by offering real-time, cross-sectional imaging that enhances decision-making during PCI. Clinical trials like ULTIMATE and IVUS-XPL have shown superior outcomes for IVUS-guided PCI in reducing major adverse cardiovascular events compared to angiography-guided procedures.
Supporting this shift, in 2023, the American College of Cardiology emphasized the integration of intravascular imaging in PCI quality improvement frameworks, urging interventional cardiologists to adopt IVUS for safer and more effective stent deployment.
(Source: ACC urges all interventional cardiologists to use intravascular imaging during PCI)
This growing clinical preference for intravascular imaging is reshaping standard PCI practices and reinforcing the relevance of IVUS in improving patient outcomes.
(Source: https://pmc.ncbi.nlm.nih.gov/articles/PMC11993872/)
Market Restraints
The high procedural cost and need for specialized training present major challenges to the broader adoption of intravascular ultrasound in clinical practice. Although IVUS offers superior imaging for coronary interventions, its accessibility is limited by the expense of the equipment and disposable catheters, which can add thousands of dollars to each procedure.
These costs are particularly burdensome for hospitals in lower-income regions or facilities with limited cardiovascular budgets. In addition to financial barriers, IVUS requires trained interventional cardiologists to interpret real-time vessel images accurately—a skill that is not yet widespread, especially outside of advanced cardiac centers.
This concern is compounded by a lack of standardized training protocols and the added time required in already constrained cath lab schedules. While some AI-assisted systems are emerging to streamline interpretation and reduce variability, they remain costly and not yet universally adopted.
For instance, "Intravascular Imaging as a Performance Measure for Percutaneous Coronary Intervention," published in Circulation: Cardiovascular Interventions in January 2025. The study highlights that while IVUS use has increased over time, significant variability remains, largely attributable to hospital and physician factors, with cost and complexity being notable barriers to its widespread adoption.
(Source: Intravascular Imaging as a Performance Measure for Percutaneous Coronary Intervention | Circulation: Cardiovascular Interventions)
Thus, without broader reimbursement support and widespread training initiatives, the financial and technical barriers of IVUS continue to restrain its global market penetration.
Market Opportunities
The IVUS market is currently anchored in standalone catheter based imaging, with clinicians relying on separate systems for vessel visualization (IVUS), physiologic measurements (iFR/FFR), and post procedure analysis. This fragmented workflow can prolong procedures and introduce interpretation variability.
Advances in AI algorithms now enable automated vessel?wall segmentation, plaque characterization, and lesion detection, addressing the need for rapid, reproducible image interpretation. Simultaneously, hybrid imaging—co registering IVUS with physiology metrics—fills critical gaps by combining structural and functional data in real time, guiding interventional decisions more precisely.
Manufacturers are already embedding these capabilities into unified platforms. For instance, at TCT 2024, Philips’ Azurion image guided therapy platform demonstrated seamless, tableside integration of IVUS and iFR co registration with AI driven controls, allowing interventionists to switch between modalities and receive automated guidance without leaving the sterile field.
(Source: https://vascularnews.com/philips-launches-latest-version-of-its-azurion-imaging-platform/)
By reducing procedural complexity, shortening catheter lab time, and standardizing image analysis, AI enabled hybrid IVUS systems offer a sustainable path to broader adoption—particularly as healthcare providers seek value based technologies that improve outcomes while optimizing resources.
We have various report editions of Intravascular Ultrasound Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
Competitive Landscape
The global intravascular ultrasound (IVUS) market is moderately consolidated, with competition centered on innovation in imaging precision, catheter design, and AI-driven procedural guidance. Leading companies are prioritizing platform integration, automation, and clinical workflow optimization to differentiate themselves. Collaborations between device manufacturers and research institutions are accelerating the development of hybrid systems that combine IVUS with complementary modalities like iFR and OCT. Additionally, companies are investing in AI-based image interpretation and cloud-enabled platforms to improve diagnostic accuracy and expand access. This innovation race is being shaped by growing clinical demand for precision-guided cardiovascular interventions and regional preferences for advanced imaging systems.
Recent Developments in the Intravascular Ultrasound (IVUS) Market
In June 2024, Philips launched its new Cardiac Workstation across Europe, the Middle East, and Africa (EMEA). This platform utilizes advanced algorithms to access, analyze, and manage electrocardiograph (ECG) data, either remotely or at the point of care. By streamlining data collection and reducing administrative workload, the Cardiac Workstation aims to enhance diagnostic cardiology, allowing clinicians to prioritize at-risk patients more effectively. This innovation reflects a broader trend towards integrating artificial intelligence in healthcare to improve patient outcomes and operational efficiency.
(Source: https://www.philips.com/a-w/about/news/archive/standard/news/press/2024/philips-aims-to-transform-diagnostic-cardiology-with-introduction-of-new-cardiac-workstation.html)
In September 2023, Boston Scientific announced that its AVVIGO+ Multi-Modality Guidance System received clearance from the U.S. Food and Drug Administration (FDA). This next-generation system integrates intravascular ultrasound (IVUS) and fractional flow reserve (FFR) technologies, enhanced by artificial intelligence (AI) capabilities through its Automated Lesion Assessment software. The system is designed to automate key procedural steps, provide precise vessel measurements, and expedite the acquisition of IVUS images during percutaneous coronary interventions (PCI). By streamlining these processes, the AVVIGO+ system aims to improve procedural efficiency and patient outcomes in the treatment of coronary artery disease. This development underscores the industry's shift towards integrating AI to enhance diagnostic precision and procedural workflows in cardiovascular interventions.
(Source: https://citoday.com/news/boston-scientifics-avvigo-guidance-system-receives-fda-clearance-and-ce-mark-approval
Boston Scientific launches AVVIGO+ Multi-Modality Guidance System in India - IndiaMedToday
https://www.healio.com/news/cardiology/20230927/boston-scientific-announces-fda-clearance-of-nextgeneration-pci-guidance-system)
Top Companies Market Share in Intravascular Ultrasound Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
Which Region Dominates the Market?
North America currently dominates the global intravascular ultrasound (IVUS) market, driven by its well-established healthcare infrastructure, high procedural volumes in interventional cardiology, and a proactive stance on adopting imaging-guided interventions. The region accounts for a substantial share of the global market due to a combination of clinical demand, supportive policy frameworks, and strong presence of leading medical device companies.
A key driver of this regional dominance is the high prevalence of cardiovascular diseases (CVDs), which remain the leading cause of death in the United States. Upon reviewing the available data, the Centers for Disease Control and Prevention (CDC) reports that approximately 4.8% of U.S. adults have ever been diagnosed with coronary heart disease as of 2023. This statistic is based on data from the National Health Interview Survey for the years 2019–2023, creating a robust and ongoing need for advanced diagnostic imaging tools such as IVUS to support effective diagnosis and intervention.
(Source: https://www.cdc.gov/nchs/fastats/heart-disease.htm)
Furthermore, the American College of Cardiology (ACC) has played a pivotal role in promoting intravascular imaging adoption. In 2023, the ACC issued updated recommendations encouraging the routine use of IVUS or OCT in percutaneous coronary interventions (PCIs), particularly for complex lesions or left main disease. These guidelines are pushing hospitals and cardiology centers to incorporate IVUS into procedural standards.
(Source: Cardiovascular Business – ACC Guidelines)
In addition to clinical needs, technological innovation and integration are also driving market leadership in North America. Companies like Philips and Boston Scientific have introduced advanced AI-powered IVUS platforms that streamline workflow, enhance diagnostic clarity, and reduce interpretation variability. Many of these systems are being piloted or commercialized first in the U.S. due to faster regulatory clearance processes and greater investment in digital health infrastructure.
Reimbursement frameworks and bundled payment models that reward outcomes-based care are also supporting the use of imaging-guided interventions. Hospitals are incentivized to reduce re-intervention rates and improve procedural outcomes—both of which IVUS directly supports.
In summary, North America’s dominance in the IVUS market is the result of a unique blend of clinical demand, policy support, advanced infrastructure, and innovation readiness, positioning the region at the forefront of global adoption. As cardiovascular care continues to shift toward precision-based, minimally invasive interventions, North America is expected to maintain its leadership throughout the forecast period.
(Source: Cardiovascular Business)
Which is the Fastest Growing Region in the Market?
Asia-Pacific is emerging as the fastest-growing region in the intravascular ultrasound (IVUS) market, fuelled by the rapid increase in cardiovascular disease (CVD) prevalence, expanding healthcare infrastructure, and rising adoption of advanced interventional imaging technologies. Countries such as Japan, China, and India are playing pivotal roles in driving regional demand, with both public and private sectors investing heavily in digital cardiology solutions.
Japan leads the region—and much of the world—in per capita IVUS usage. Over 80% of percutaneous coronary interventions (PCIs) performed in Japanese hospitals utilize IVUS, largely due to government reimbursement policies and a long-standing clinical preference for imaging-guided interventions. A 2023 review published by the Japanese Circulation Society attributes Japan’s leadership in IVUS adoption to its early clinical integration, investment in operator training, and support for precision-guided therapy.
(Source: PubMed Central – IVUS in Japan)
Meanwhile, China is experiencing exponential growth in cardiovascular imaging as part of its national “Healthy China 2030” strategy. The country has invested in upgrading over 1,500 hospitals with advanced catheterization labs and is encouraging digital imaging adoption through government funding and local innovation. In 2024, several Chinese hospitals partnered with device manufacturers to integrate AI-powered IVUS systems into cardiac centers, particularly in urban Tier 1 and Tier 2 cities.
(Source: Regulatory responses and approval status of artificial intelligence medical devices with a focus on China - PubMed)
India is also witnessing growing uptake of IVUS technology, supported by a surge in private-sector cardiac specialty centers and increased procedural volumes related to coronary artery disease. While access remains limited in rural areas, urban hospitals are adopting imaging-guided PCI to improve procedural outcomes and reduce stent-related complications.
(Source: 3734_pdf.pdf)
In summary, Asia-Pacific is positioning itself as a dynamic growth hub for the IVUS market. The combination of high disease burden, government-backed modernization efforts, and clinical advocacy for image-guided cardiology continues to push the region forward. As reimbursement models evolve and clinician training expands, Asia-Pacific is expected to account for an increasing share of global IVUS procedures in the years ahead.
(Source: PMC)
The current report Scope analyzes Intravascular Ultrasound Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
Global Intravascular Ultrasound Market Report 2025 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Intravascular Ultrasound Industry growth. Intravascular Ultrasound market has been segmented with the help of its Type, End-user , and others. Intravascular Ultrasound market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
The IVUS market is primarily segmented into two major product types: IVUS consoles and IVUS catheters. Consoles serve as the core imaging workstations used to process, display, and store real-time vascular images, while catheters are disposable, miniaturized ultrasound probes inserted into the blood vessels during a procedure. Among these, IVUS catheters dominate the product segment due to their indispensable role in every intravascular ultrasound examination. These catheters contain high-frequency transducers that emit and receive ultrasound signals as they travel through the artery, generating detailed images of the vessel wall. Their precision is critical in determining lesion severity, plaque morphology, and stent sizing during percutaneous coronary interventions (PCI). Leading manufacturers such as Boston Scientific and Terumo have introduced advanced catheters with improved flexibility, imaging resolution, and compatibility with rapid-exchange systems to simplify procedural workflows. For instance, Boston Scientific’s OptiCross HD catheter is engineered for high-resolution imaging, particularly in tortuous and calcified vessels, enhancing physician confidence during complex interventions.
(Source: OPTICROSS™ HD Coronary Imaging Catheters – Boston Scientific)
The continued evolution of catheter design is directly influencing the accuracy, efficiency, and clinical outcomes of IVUS-guided therapies.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Intravascular Ultrasound Industry. Request a Free Sample PDF!
The IVUS market is segmented by end-use into hospitals and specialty clinics. Hospitals represent the largest end-user category, as they house the infrastructure, cardiac catheterization labs, and trained personnel necessary for advanced cardiovascular procedures. However, hospitals remain the primary and most critical users of IVUS systems, especially for complex cases requiring high procedural precision and imaging-guided intervention. These institutions often participate in large-scale clinical trials and implement advanced imaging protocols as part of their interventional cardiology services. As reimbursement policies evolve to support quality-focused care, hospitals are further incentivized to use intravascular imaging to minimize post-procedural complications and readmission rates. Tertiary-care centers in countries like the U.S., Germany, and Japan are key hubs for IVUS utilization, offering integrated platforms that combine IVUS with other diagnostic modalities such as optical coherence tomography (OCT) or fractional flow reserve (FFR). For instance, Mayo Clinic’s cardiovascular division employs hybrid IVUS-OCT systems for both diagnostic and interventional purposes, aligning with global trends in precision-guided cardiovascular therapy.
(Source: Cardiovascular Medicine - Department home - Mayo Clinic)
Specialty clinics, while growing in number, typically lack the full-scale imaging infrastructure seen in hospital settings but are expected to become more prominent as outpatient cardiac care continues to expand.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
Research Associate at Cognitive Market Research
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.
Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the medical devices & consumables industry. She has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services. Her expertise in Market Research and business intelligence has equipped her with the skills necessary to analyze complex information and provide strategic recommendations.
In her current role, Anushka is a highly motivated and detail-oriented research analyst with a passion for uncovering valuable insights from data. She thrives in dynamic environments where her analytical abilities and research expertise can contribute to informed decision-making for businesses. Her collaborative approach facilitated effective communication of insights, fostering a data-driven culture within the organization.Anushka remains an invaluable asset in the dynamic landscape of market research.
Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.
The Global Intravascular Ultrasound Market is witnessing significant growth in the near future.
In 2023, the Accessories segment accounted for noticeable share of global Intravascular Ultrasound Market and is projected to experience significant growth in the near future.
The Hospitals segment is expected to expand at the significant CAGR retaining position throughout the forecast period.
Some of the key companies Boston Scientific Corporation , Terumo Corporation and others are focusing on its strategy building model to strengthen its product portfolio and expand its business in the global market.
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type | Accessories, IVUS Consoles, IVUS Catheters |
End-user | Hospitals, Specialty Clinics |
List of Competitors | Boston Scientific Corporation , Koninklijke Philips N.V., Terumo Corporation , Infraredx Inc., ACIST Medical Systems, Siemens Medical Solutions USA, Inc., Conavi Medical |
This chapter will help you gain GLOBAL Market Analysis of Intravascular Ultrasound. Further deep in this chapter, you will be able to review Global Intravascular Ultrasound Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Intravascular Ultrasound. Further deep in this chapter, you will be able to review North America Intravascular Ultrasound Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Intravascular Ultrasound. Further deep in this chapter, you will be able to review Europe Intravascular Ultrasound Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Intravascular Ultrasound. Further deep in this chapter, you will be able to review Asia Pacific Intravascular Ultrasound Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Intravascular Ultrasound. Further deep in this chapter, you will be able to review South America Intravascular Ultrasound Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East Market Analysis of Intravascular Ultrasound. Further deep in this chapter, you will be able to review Middle East Intravascular Ultrasound Market Split by various segments and Country Split.
Chapter 6 Middle East Market Analysis
This chapter will help you gain Middle East Market Analysis of Intravascular Ultrasound. Further deep in this chapter, you will be able to review Middle East Intravascular Ultrasound Market Split by various segments and Country Split.
Chapter 7 Africa Market Analysis
This chapter provides an in-depth analysis of the market share among key competitors of Intravascular Ultrasound. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Analysis 2019 -2031, will provide market size split by Type. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Analysis 2021 - 2033
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by End-user Analysis 2021 - 2033
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Intravascular Ultrasound market
Chapter 12 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Chapter 13 Research Methodology and Sources
Why Accessories have a significant impact on Intravascular Ultrasound market? |
What are the key factors affecting the Accessories and IVUS Consoles of Intravascular Ultrasound Market? |
What is the CAGR/Growth Rate of Hospitals during the forecast period? |
By type, which segment accounted for largest share of the global Intravascular Ultrasound Market? |
Which region is expected to dominate the global Intravascular Ultrasound Market within the forecast period? |